Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Adams

Showing results (791-800 of 831) with videos related to

Pageof 84
Sort By:
Circulation. Heart Failure|October 5, 2020
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart FailureDavid E Lanfear, Jasmine A Luzum, Ruicong She, et al.
Journal of Cardiac Failure|March 3, 2011
Coping effectively with heart failure (COPE-HF): design and rationale of a telephone-based coping skills interventionAndrew Sherwood, Christopher M O'Connor, Faye S Routledge, et al.
European Journal of Heart Failure|August 10, 2013
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering propertiesDaniela Dobre, Jeffrey S Borer, Kim Fox, et al.
Studies in Health Technology and Informatics|January 4, 2018
Technical Challenges and Opportunities when Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health RecordPedro J Caraballo, Joseph A Sutton, Ann M Moyer, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
JAMA|August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialG Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.
Nature Medicine|August 31, 2025
Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trialBarry A Borlaug, Jeffrey M Testani, Mark C Petrie, et al.
American Heart Journal|April 21, 2009
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) RegistryKirkwood F Adams, James H Patterson, John H Patterson, et al.
JACC. Heart Failure|September 8, 2014
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart FailureG Michael Felker, Tariq Ahmad, Kevin J Anstrom, et al.
Microbiology Resource Announcements|March 6, 2024
Genome sequences of actinobacteriophages JorRay, Blocker23, Nibbles, and OlgasCloverBreanna M Baumgartner, Kayla A Bono, Dawn R McIntosh, et al.
Pageof 84

Showing results (791-800 of 831) with videos related to

Sort By:
Pageof 84
Circulation. Heart Failure|October 5, 2020
Polygenic Score for β-Blocker Survival Benefit in European Ancestry Patients With Reduced Ejection Fraction Heart FailureDavid E Lanfear, Jasmine A Luzum, Ruicong She, et al.
Journal of Cardiac Failure|March 3, 2011
Coping effectively with heart failure (COPE-HF): design and rationale of a telephone-based coping skills interventionAndrew Sherwood, Christopher M O'Connor, Faye S Routledge, et al.
European Journal of Heart Failure|August 10, 2013
Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering propertiesDaniela Dobre, Jeffrey S Borer, Kim Fox, et al.
Studies in Health Technology and Informatics|January 4, 2018
Technical Challenges and Opportunities when Implementing Pharmacogenomics Decision Support Integrated in the Electronic Health RecordPedro J Caraballo, Joseph A Sutton, Ann M Moyer, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
JAMA|August 23, 2017
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialG Michael Felker, Kevin J Anstrom, Kirkwood F Adams, et al.
Nature Medicine|August 31, 2025
Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trialBarry A Borlaug, Jeffrey M Testani, Mark C Petrie, et al.
American Heart Journal|April 21, 2009
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) RegistryKirkwood F Adams, James H Patterson, John H Patterson, et al.
JACC. Heart Failure|September 8, 2014
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart FailureG Michael Felker, Tariq Ahmad, Kevin J Anstrom, et al.
Microbiology Resource Announcements|March 6, 2024
Genome sequences of actinobacteriophages JorRay, Blocker23, Nibbles, and OlgasCloverBreanna M Baumgartner, Kayla A Bono, Dawn R McIntosh, et al.
Pageof 84